Staywell Formulation Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.84 Cr
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.80 Cr
- Satisfied Charges ₹ 6.60 Cr
- Revenue Growth -52.28%
- Profit Growth 66.79%
- Ebitda 122.29%
- Net Worth -7.76%
- Total Assets -3.29%
About Staywell Formulation
Staywell Formulation Private Limited (SFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 November 2007 and has a history of 17 years and two months. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.84 Cr.
The company currently has active open charges totaling ₹11.80 Cr. The company has closed loans amounting to ₹6.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vikash Santuka and Suresh Santuka serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24233DL2007PTC170595
- Company No.
170595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Staywell Formulation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikash Santuka  | Director | 21-Dec-2015 | Current |
| Suresh Santuka | Director | 21-Dec-2015 | Current |
Financial Performance of Staywell Formulation.
Staywell Formulation Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.28% decrease. The company also saw a substantial improvement in profitability, with a 66.79% increase in profit. The company's net worth dipped by a decrease of 7.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Staywell Formulation?
In 2023, Staywell Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Santuka Associates Private LimitedVikash Santuka and Suresh Santuka are mutual person
- S A Logistics Private Limited
Vikash Santuka is a mutual person
- Naomi Laboratories Private Limited
Suresh Santuka is a mutual person
- Santuka Homes Private Limited
Suresh Santuka is a mutual person
Charges (Loans)
₹11.80 Cr
₹6.60 Cr
Charges Breakdown by Lending Institutions
- Dena Bank : 11.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2012 | Dena Bank | ₹11.80 Cr | Open |
| 27 Mar 2010 | Canara Bank | ₹8.00 M | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹5.00 M | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹3.30 Cr | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹2.00 Cr | Satisfied |
How Many Employees Work at Staywell Formulation?
Staywell Formulation has a workforce of 32 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Staywell Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Staywell Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
